Principal Financial Group’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $61.7K | Buy |
16,949
+2,632
| +18% | +$9.58K | ﹤0.01% | 2187 |
|
|
2025
Q1 | $27.5K | Buy |
14,317
+2,096
| +17% | +$4.02K | ﹤0.01% | 2140 |
|
|
2024
Q4 | $23.2K | Sell |
12,221
-3,556
| -23% | -$6.76K | ﹤0.01% | 2196 |
|
|
2024
Q3 | $20.8K | Sell |
15,777
-5,336
| -25% | -$7.04K | ﹤0.01% | 2208 |
|
|
2024
Q2 | $21.5K | Buy |
+21,113
| New | +$21.5K | ﹤0.01% | 2336 |
|
|
2022
Q4 | – | Sell |
-164,028
| Closed | -$52K | – | 2443 |
|
|
2022
Q3 | $52K | Sell |
164,028
-250,364
| -60% | -$79.4K | ﹤0.01% | 2408 |
|
|
2022
Q2 | $146K | Buy |
414,392
+229,453
| +124% | +$80.8K | ﹤0.01% | 2343 |
|
|
2022
Q1 | $132K | Sell |
184,939
-73,624
| -28% | -$52.5K | ﹤0.01% | 2400 |
|
|
2021
Q4 | $584K | Sell |
258,563
-281,269
| -52% | -$635K | ﹤0.01% | 2089 |
|
|
2021
Q3 | $1.55M | Sell |
539,832
-8,036
| -1% | -$23.1K | ﹤0.01% | 1912 |
|
|
2021
Q2 | $2.08M | Sell |
547,868
-25,369
| -4% | -$96.1K | ﹤0.01% | 1897 |
|
|
2021
Q1 | $1.94M | Buy |
573,237
+36,084
| +7% | +$122K | ﹤0.01% | 1859 |
|
|
2020
Q4 | $1.5M | Buy |
537,153
+402,876
| +300% | +$1.13M | ﹤0.01% | 1857 |
|
|
2020
Q3 | $337K | Buy |
134,277
+40,743
| +44% | +$102K | ﹤0.01% | 2110 |
|
|
2020
Q2 | $1.27M | Buy |
93,534
+63,000
| +206% | +$855K | ﹤0.01% | 1780 |
|
|
2020
Q1 | $231K | Buy |
30,534
+13,183
| +76% | +$99.7K | ﹤0.01% | 2033 |
|
|
2019
Q4 | $110K | Sell |
17,351
-11,049
| -39% | -$70K | ﹤0.01% | 2180 |
|
|
2019
Q3 | $111K | Buy |
28,400
+10,527
| +59% | +$41.1K | ﹤0.01% | 2176 |
|
|
2019
Q2 | $87K | Buy |
17,873
+6,664
| +59% | +$32.4K | ﹤0.01% | 2188 |
|
|
2019
Q1 | $92K | Sell |
11,209
-1,593
| -12% | -$13.1K | ﹤0.01% | 2158 |
|
|
2018
Q4 | $71K | Buy |
+12,802
| New | +$71K | ﹤0.01% | 2185 |
|